{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T00:05:41Z","timestamp":1779840341462,"version":"3.53.1"},"reference-count":56,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,21]],"date-time":"2026-03-21T00:00:00Z","timestamp":1774051200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004731","name":"Zhejiang Province Natural Science Foundation","doi-asserted-by":"publisher","award":["LY24H160003"],"award-info":[{"award-number":["LY24H160003"]}],"id":[{"id":"10.13039\/501100004731","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81772919"],"award-info":[{"award-number":["81772919"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jbc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Biological Chemistry"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.jbc.2026.111404","type":"journal-article","created":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T08:02:02Z","timestamp":1774512122000},"page":"111404","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Fragile histidine triad (FHIT) suppresses gastric cancer via translational regulation of the epigenetic modifier KDM6B"],"prefix":"10.1016","volume":"302","author":[{"given":"Haorui","family":"Hu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuming","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongyan","family":"Qi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guiling","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Runan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6157-8293","authenticated-orcid":false,"given":"Jing","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jbc.2026.111404_bib1","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1136\/gutjnl-2019-320234","article-title":"Is gastric cancer becoming a rare disease? A global assessment of predicted incidence trends to 2035","volume":"69","author":"Arnold","year":"2020","journal-title":"Gut"},{"key":"10.1016\/j.jbc.2026.111404_bib2","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.jbc.2026.111404_bib3","doi-asserted-by":"crossref","first-page":"1802","DOI":"10.1136\/gutjnl-2022-328514","article-title":"Steps forward in understanding gastric cancer risk","volume":"72","author":"Rugge","year":"2023","journal-title":"Gut"},{"key":"10.1016\/j.jbc.2026.111404_bib4","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1038\/s41568-021-00412-7","article-title":"Mapping the genomic Diaspora of gastric cancer","volume":"22","author":"Yeoh","year":"2022","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.jbc.2026.111404_bib5","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s13045-024-01654-2","article-title":"Helicobacter pylori and gastric cancer: mechanisms and new perspectives","volume":"18","author":"Duan","year":"2025","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.jbc.2026.111404_bib6","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/S0140-6736(20)31288-5","article-title":"Gastric cancer","volume":"396","author":"Smyth","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.jbc.2026.111404_bib7","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1016\/S1470-2045(02)00931-2","article-title":"FHIT: from gene discovery to cancer treatment and prevention","volume":"3","author":"Pekarsky","year":"2002","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.jbc.2026.111404_bib8","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1016\/S0959-8049(01)00432-4","article-title":"High frequency of LOH, MSI and abnormal expression of FHIT in gastric cancer","volume":"38","author":"Huiping","year":"2002","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.jbc.2026.111404_bib9","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1038\/sj.bjc.6600937","article-title":"Cancer and the FRA3B\/FHIT fragile locus: it's a HIT","volume":"88","author":"Huebner","year":"2003","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.jbc.2026.111404_bib10","doi-asserted-by":"crossref","first-page":"3346","DOI":"10.1073\/pnas.061020098","article-title":"FHIT gene therapy prevents tumor development in Fhit-deficient mice","volume":"98","author":"Dumon","year":"2001","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jbc.2026.111404_bib11","doi-asserted-by":"crossref","first-page":"11529","DOI":"10.1021\/bi961415t","article-title":"Fhit, a putative tumor suppressor in humans, is a dinucleoside 5',5'''-P-1,P-3-triphosphate hydrolase","volume":"35","author":"Barnes","year":"1996","journal-title":"Biochemistry-Us"},{"key":"10.1016\/j.jbc.2026.111404_bib12","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1186\/s12943-017-0749-x","article-title":"Impact of FHIT loss on the translation of cancer-associated mRNAs","volume":"16","author":"Kiss","year":"2017","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.jbc.2026.111404_bib13","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.gde.2016.03.010","article-title":"Histone demethylases in physiology and cancer: a tale of two enzymes, JMJD3 and UTX","volume":"36","author":"Arcipowski","year":"2016","journal-title":"Curr. Opin. Genet. Dev."},{"key":"10.1016\/j.jbc.2026.111404_bib14","first-page":"1","article-title":"The cancer driver genes IDH1\/2, JARID1C\/KDM5C, and UTX\/KDM6A: crosstalk between histone demethylation and hypoxic reprogramming in cancer metabolism","volume":"51","author":"Chang","year":"2019","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.jbc.2026.111404_bib15","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.biochi.2021.02.005","article-title":"KDM6B (JMJD3) and its dual role in cancer","volume":"184","author":"Lagunas-Rangel","year":"2021","journal-title":"Biochimie"},{"key":"10.1016\/j.jbc.2026.111404_bib16","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1038\/s41598-018-37340-w","article-title":"Comprehensive profiling of JMJD3 in gastric cancer and its influence on patient survival","volume":"9","author":"Xu","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jbc.2026.111404_bib17","article-title":"The histone lysine demethylase JMJD3\/KDM6B is recruited to p53 bound promoters and enhancer elements in a p53 dependent manner","volume":"9","author":"Williams","year":"2014","journal-title":"Plos One"},{"key":"10.1016\/j.jbc.2026.111404_bib18","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1038\/s41389-020-0195-2","article-title":"STAT3 activates MSK1-mediated histone H3 phosphorylation to promote NFAT signaling in gastric carcinogenesis","volume":"9","author":"Qi","year":"2020","journal-title":"Oncogenesis"},{"key":"10.1016\/j.jbc.2026.111404_bib19","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.bbagrm.2017.01.005","article-title":"Identification of Fhit as a post-transcriptional effector of Thymidine Kinase 1 expression","volume":"1860","author":"Kiss","year":"2017","journal-title":"Biochim. Biophys. Acta Gene Regul. Mech."},{"key":"10.1016\/j.jbc.2026.111404_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2019.109384","article-title":"The role and prospect of JMJD3 in stem cells and cancer","volume":"118","author":"Yin","year":"2019","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.jbc.2026.111404_bib21","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1007\/s12094-021-02773-9","article-title":"Emerging roles of JMJD3 in cancer","volume":"24","author":"Farzaneh","year":"2022","journal-title":"Clin. Transl. Oncol."},{"key":"10.1016\/j.jbc.2026.111404_bib22","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1007\/s00432-002-0409-3","article-title":"Loss of FHIT protein expression correlates with disease progression and poor differentiation in gastric cancer","volume":"129","author":"Rocco","year":"2003","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"10.1016\/j.jbc.2026.111404_bib23","doi-asserted-by":"crossref","first-page":"108261","DOI":"10.18632\/oncotarget.22369","article-title":"FHIT down-regulation was inversely linked to aggressive behaviors and adverse prognosis of gastric cancer: a meta- and bioinformatics analysis","volume":"8","author":"Zheng","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.jbc.2026.111404_bib24","article-title":"Tanshinones induce tumor cell apoptosis via directly targeting FHIT","volume":"11","author":"Zhou","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jbc.2026.111404_bib25","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1093\/protein\/10.12.1461","article-title":"Purification and crystallization of complexes modeling the active state of the fragile histidine triad protein","volume":"10","author":"Brenner","year":"1997","journal-title":"Protein Eng."},{"key":"10.1016\/j.jbc.2026.111404_bib26","doi-asserted-by":"crossref","first-page":"5484","DOI":"10.1073\/pnas.95.10.5484","article-title":"Genetic, biochemical, and crystallographic characterization of fhit-substrate complexes as the active signaling form of fhit","volume":"95","author":"Pace","year":"1998","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jbc.2026.111404_bib27","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1073\/pnas.0437915100","article-title":"Designed FHIT alleles establish that Fhit-induced apoptosis in cancer cells is limited by substrate binding","volume":"100","author":"Trapasso","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jbc.2026.111404_bib28","doi-asserted-by":"crossref","first-page":"8613","DOI":"10.1021\/jacs.2c00815","article-title":"Chemical proteomics of the tumor suppressor Fhit covalently bound to the cofactor Ap(3)A elucidates its inhibitory action on translation","volume":"144","author":"Herzog","year":"2022","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.jbc.2026.111404_bib29","doi-asserted-by":"crossref","first-page":"3101","DOI":"10.1002\/2211-5463.13303","article-title":"Ferritin heavy chain (FTH1) exerts significant antigrowth effects in breast cancer cells by inhibiting the expression of c-MYC","volume":"11","author":"Ali","year":"2021","journal-title":"Febs. Open Bio."},{"key":"10.1016\/j.jbc.2026.111404_bib30","doi-asserted-by":"crossref","first-page":"1998","DOI":"10.1093\/nar\/gkx1248","article-title":"A FTH1 gene: pseudogene: microRNA network regulates tumorigenesis in prostate cancer","volume":"46","author":"Chan","year":"2018","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.jbc.2026.111404_bib31","doi-asserted-by":"crossref","first-page":"2309387","DOI":"10.1002\/advs.202309387","article-title":"Multilevel regulation of NF-\u03baB signaling by NSD2 suppresses-driven pancreatic tumorigenesis","volume":"11","author":"Feng","year":"2024","journal-title":"Adv. Sci."},{"key":"10.1016\/j.jbc.2026.111404_bib32","doi-asserted-by":"crossref","DOI":"10.1172\/JCI153167","article-title":"Histone methyltransferase WHSC1 loss dampens MHC-I antigen presentation pathway to impair IFN-\u03b3 stimulated antitumor immunity","volume":"132","author":"Ren","year":"2022","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.jbc.2026.111404_bib33","first-page":"a014290","article-title":"The role of MIZ-1 in MYC-Dependent tumorigenesis","volume":"3","author":"Wiese","year":"2013","journal-title":"Csh Perspect. Med."},{"key":"10.1016\/j.jbc.2026.111404_bib34","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.oraloncology.2018.08.022","article-title":"The role of protein methyltransferases as potential novel therapeutic targets in squamous cell carcinoma of the head and neck (vol 81, pg 100, 2018)","volume":"86","author":"Saloura","year":"2018","journal-title":"Oral Oncol."},{"key":"10.1016\/j.jbc.2026.111404_bib35","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.canlet.2020.05.025","article-title":"Hypoxia-driven epigenetic regulation in cancer progression: a focus on histone methylation and its modifying enzymes","volume":"489","author":"Kim","year":"2020","journal-title":"Cancer Lett."},{"key":"10.1016\/j.jbc.2026.111404_bib36","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/s12943-017-0596-9","article-title":"Epigenetics in cancer stem cells","volume":"16","author":"Toh","year":"2017","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.jbc.2026.111404_bib37","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1186\/s13045-020-00937-8","article-title":"EZH2: a novel target for cancer treatment","volume":"13","author":"Duan","year":"2020","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.jbc.2026.111404_bib38","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1182\/blood.2020008743","article-title":"KDM5 inhibition offers a novel therapeutic strategy for the treatment of KMT2D mutant lymphomas","volume":"138","author":"Heward","year":"2021","journal-title":"Blood"},{"key":"10.1016\/j.jbc.2026.111404_bib39","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1038\/s41416-024-02825-1","article-title":"Impact of clonal TP53 mutations with loss of heterozygosity on adjuvant chemotherapy and immunotherapy in gastric cancer","volume":"131","author":"Gu","year":"2024","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.jbc.2026.111404_bib40","doi-asserted-by":"crossref","first-page":"7777","DOI":"10.1021\/jf071520h","article-title":"Pterostilbene induces apoptosis and cell cycle arrest in human gastric carcinoma cells","volume":"55","author":"Pan","year":"2007","journal-title":"J. Agric. Food Chem."},{"key":"10.1016\/j.jbc.2026.111404_bib41","doi-asserted-by":"crossref","first-page":"6568","DOI":"10.1038\/s41598-024-57099-7","article-title":"Noxa inhibits oncogenesis through ZNF519 in gastric cancer and is suppressed by hsa-miR-200b-3p","volume":"14","author":"Shi","year":"2024","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jbc.2026.111404_bib42","doi-asserted-by":"crossref","first-page":"3140","DOI":"10.3892\/or.2015.4276","article-title":"Silencing beta-linked N-acetylglucosamine transferase induces apoptosis in human gastric cancer cells through PUMA and caspase-3 pathways","volume":"34","author":"Wen","year":"2015","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.jbc.2026.111404_bib43","first-page":"37","article-title":"P53 nuclear stabilization is associated with FHIT loss and younger age of onset in squamous cell carcinoma of oral tongue","volume":"9","author":"Sr","year":"2014","journal-title":"BMC Clin. Pathol."},{"key":"10.1016\/j.jbc.2026.111404_bib44","doi-asserted-by":"crossref","first-page":"5439","DOI":"10.1038\/onc.2017.249","article-title":"FHIT loss confers cisplatin resistance in lung cancer via the AKT\/NF-kappaB\/Slug-mediated PUMA reduction","volume":"36","author":"Wu","year":"2017","journal-title":"Oncogene"},{"key":"10.1016\/j.jbc.2026.111404_bib45","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1097\/JTO.0b013e318244aed0","article-title":"Inactivation of both FHIT and p53 cooperate in deregulating proliferation-related pathways in lung cancer","volume":"7","author":"Andriani","year":"2012","journal-title":"J. Thorac. Oncol."},{"key":"10.1016\/j.jbc.2026.111404_bib46","doi-asserted-by":"crossref","first-page":"342","DOI":"10.2174\/156800908785133204","article-title":"FHIT and p53 status and response to platinum-based treatment in advanced non-small cell lung cancer","volume":"8","author":"Cortinovis","year":"2008","journal-title":"Curr. Cancer Drug Targets"},{"key":"10.1016\/j.jbc.2026.111404_bib47","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1038\/s41419-019-1388-5","article-title":"NETO2 promotes invasion and metastasis of gastric cancer cells via activation of PI3K\/Akt\/NF-kappaB\/Snail axis and predicts outcome of the patients","volume":"10","author":"Liu","year":"2019","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.jbc.2026.111404_bib48","doi-asserted-by":"crossref","DOI":"10.1016\/j.cyto.2021.155658","article-title":"ThPOK transcriptionally inactivates TNFRSF12A to increase the proliferation of T cells with the involvement of the NF-kB pathway","volume":"148","author":"Xia","year":"2021","journal-title":"Cytokine"},{"key":"10.1016\/j.jbc.2026.111404_bib49","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2021.108429","article-title":"TNFSF9 promotes metastasis of pancreatic cancer by regulating M2 polarization of macrophages through Src\/FAK\/p-Akt\/IL-1beta signaling","volume":"102","author":"Wu","year":"2022","journal-title":"Int. Immunopharmacol"},{"key":"10.1016\/j.jbc.2026.111404_bib50","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1038\/s41419-019-2131-y","article-title":"Gastric cancer-derived mesenchymal stromal cells trigger M2 macrophage polarization that promotes metastasis and EMT in gastric cancer","volume":"10","author":"Li","year":"2019","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.jbc.2026.111404_bib51","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/S0014-5793(98)00791-1","article-title":"Identification and functional characterization of DR6, a novel death domain-containing TNF receptor","volume":"431","author":"Pan","year":"1998","journal-title":"Febs Lett."},{"key":"10.1016\/j.jbc.2026.111404_bib52","doi-asserted-by":"crossref","first-page":"2606","DOI":"10.3390\/ijms21072606","article-title":"The epigenetic profile of tumor endothelial cells. Effects of combined therapy with antiangiogenic and epigenetic drugs on cancer progression","volume":"21","author":"Ciesielski","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jbc.2026.111404_bib53","doi-asserted-by":"crossref","DOI":"10.1177\/17588359231220511","article-title":"The role of aberrant DNA methylation in cancer initiation and clinical impacts","volume":"16","author":"Geissler","year":"2024","journal-title":"Ther. Adv. Med. Oncol."},{"key":"10.1016\/j.jbc.2026.111404_bib54","doi-asserted-by":"crossref","first-page":"915","DOI":"10.18632\/oncotarget.2821","article-title":"DNA methylome analysis identifies epigenetic silencing of FHIT as a determining factor for radiosensitivity in oral cancer: an outcome-predicting and treatment-implicating study","volume":"6","author":"Lin","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.jbc.2026.111404_bib55","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1038\/s41420-023-01489-9","article-title":"Histone demethylases in the regulation of immunity and inflammation","volume":"9","author":"Qu","year":"2023","journal-title":"Cell Death Discov."},{"key":"10.1016\/j.jbc.2026.111404_bib56","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.adh2708","article-title":"KDM6B drives epigenetic reprogramming associated with lymphoid stromal cell early commitment and immune properties","volume":"9","author":"Sylvestre","year":"2023","journal-title":"Sci. Adv."}],"container-title":["Journal of Biological Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021925826002747?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021925826002747?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,26]],"date-time":"2026-05-26T23:41:22Z","timestamp":1779838882000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021925826002747"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":56,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["S0021925826002747"],"URL":"https:\/\/doi.org\/10.1016\/j.jbc.2026.111404","relation":{},"ISSN":["0021-9258"],"issn-type":[{"value":"0021-9258","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Fragile histidine triad (FHIT) suppresses gastric cancer via translational regulation of the epigenetic modifier KDM6B","name":"articletitle","label":"Article Title"},{"value":"Journal of Biological Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jbc.2026.111404","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc on behalf of American Society for Biochemistry and Molecular Biology.","name":"copyright","label":"Copyright"}],"article-number":"111404"}}